STAT+: South Africa investigates Johnson & Johnson over ‘excessive pricing’ for its TB drug
South African authorities are investigating Johnson & Johnson and its Janssen subsidiary over “excessive pricing”…
Category: Life Sciences
STAT+: Chamber of Commerce, government clash at first court hearing on Medicare drug prices
WASHINGTON — Attorneys for the U.S. Chamber of Commerce and the federal government sparred Friday…
STAT+: Dana-Farber deal highlights a surprising trend: New cancer centers are in vogue
Boston isn’t the only city slated for a new cancer center. Far from it. There’s…
STAT+: Dana-Farber blindsided Brigham and Women’s. The blowback will be strong
This column is from Trendlines, a business newsletter that covers the forces shaping the economy…
STAT+: Pharmalittle: House panel inches into fixing drug shortages; pharma could face legal action over improper patent listings
And so, another working week will soon draw to a close. Not a moment too…
Opinion: The morally ground-shifting legacy of Ian Wilmut and Dolly the sheep
Ian Wilmut, the British scientist behind the first-ever cloning of a mammal, died Sept. 10,…
Opinion: How the Wegovy shortage is making life impossible for my patients — and for me
There is just not enough Wegovy. The current manufacturing shortage will eventually end, and those…
Polio transmission was supposed to end by 2023. A new report explains why it won’t.
The latest goal for the end of polio transmission will almost certainly not be met,…
Randomized controlled trials are the ‘gold standard’ of research — but a difficult fit for trans care
In order to provide gender-affirming care, clinicians must sometimes jump through unusual hoops. In Australia,…
Integrative Medicine | Maine Medical Center | Portland, ME – MaineHealth
Integrative Medicine | Maine Medical Center | Portland, ME MaineHealth Read Original Article: Integrative Medicine |…
Johnson & Johnson is getting rid of its script logo after more than 130 years
Johnson & Johnson is signing off on a new logo. The health care giant said…
Listen: Covid’s latest surge, Alnylam at the FDA, & the end of an era
What does Covid-19 have in store for the winter? When are good data not good…
STAT+: House subcommittee forays into fixing drug shortages
WASHINGTON — A House subcommittee took a first step today toward legislation to fix drug…
STAT+: FTC warns drugmakers they can face legal action over improper patent filings
The Federal Trade Commission warned pharmaceutical companies they could face legal action if they improperly…
STAT+: Dana-Farber, in break with Brigham and Women’s, will build new cancer center with Beth Israel
Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center have announced plans to build a…
Pig kidney works a record two months in donated body, raising hope for animal-human transplants
NEW YORK — Dozens of doctors and nurses silently lined the hospital hallway in tribute:…
New Senate deal would ban some facility fees, reform hospital contracting
WASHINGTON — A new, bipartisan deal in the Senate to fund primary care programs also…
STAT+: Medicare is urged to monitor how rebates affect Part D drug spending, but agency demurs
The U.S. government should monitor the effect that rebates have on Medicare Part D plans…
STAT+: New study adds to evidence on psychedelic as effective treatment for PTSD
MDMA is a safe and effective treatment for post-traumatic stress disorder in a racially and…
STAT+: Pharmalittle: White House imposes price limits for Regeneron Covid drug; lawmakers push federal agencies to prevent patent abuses
Top of the morning to you. And a fine one it is. Lots of sunshine…
STAT+: Machine learning biotech raises $273 million in rare successful late-stage round
Biotech startup Generate Biomedicines, which uses artificial intelligence to find new drugs, raised $273 million…
The ‘Hispanic Paradox’ intrigues a new generation of researchers determined to unravel it
For 40 years, researchers have unsuccessfully tried to explain — or debunk — the “Hispanic…
STAT+: Civica Rx considers moving into chemo drugs as shortages worsen
WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a…
Novelist John Green launches attack on Cepheid over the price of its TB test
John Green, a novelist and high-profile YouTuber, is once again leveraging his star power in…
Opinion: Long Covid is a new name for an old syndrome
Long Covid goes by many names. Today, it is no longer a new public health enigma,…
STAT+: FDA panel endorses Alnylam’s heart drug — after picking apart its supporting data
A group of advisers to the Food and Drug Administration voted in favor of Alnylam…
STAT+: What to make of Biden’s latest cancer moonshot efforts
WASHINGTON — The next chapter of President Biden’s moonshot to end cancer has landed. While…
STAT+: Akili abandons prescription business model, to lay off 40% of workers
Akili Interactive, which in 2020 made waves by receiving Food and Drug Administration clearance for…
.jpg)
STAT+: Lawmakers introduce bill to require drugmakers to provide key info to both FDA and U.S. Patent Office
Amid concerns over monopolies held by drugmakers, a bipartisan group of lawmakers introduced a bill…
STAT+: In new Regeneron deal for Covid drug, Biden administration imposes price limits for first time
WASHINGTON — A groundbreaking clause in a new deal between the Department of Health and…
STAT+: Pharmalittle: FDA panel says popular decongestant doesn’t work; U.S. warns companies over illegally marketed eye products
Good morning, everyone, and how are you today? We are doing just fine, thank you….
Opinion: PEPFAR, one of the greatest public health inventions of our time, is at risk
In the clinic where I work, I met a patient the other day whom I…
Opinion: STAT+: The IRA needs changes to better support patients with rare diseases
This time last year, members of Congress were working around the clock to draft and…
STAT+: How Silicon Valley’s hospital whisperer bridges the gap between startups and health systems
SAN FRANCISCO — As part of one of the tech industry’s most revered venture funds,…
They’re immigrants, farmworkers, and new moms. And they’re facing postpartum depression at higher rates
Over more than a decade working with immigrant farmworkers in the public clinics of the…
Not All Fruits Play Well Together in Your Morning Smoothie – WebMD
Not All Fruits Play Well Together in Your Morning Smoothie WebMD Read Original Article: Not All…
Best ozempic alternatives: 25 best products – DISCOVER Magazine
Best ozempic alternatives: 25 best products DISCOVER Magazine Read Original Article: Best ozempic alternatives: 25 best…
Eye on Health: Minimally invasive procedure offers alternative surgery for heart patients – WSBT-TV
Eye on Health: Minimally invasive procedure offers alternative surgery for heart patients WSBT-TV Read Original Article:…
.jpg)
New Covid vaccine is recommended by CDC for everyone 6 months or older
A panel of advisers to the Centers for Disease Control and Prevention voted 13-1 Tuesday…
Food companies to regulators: Please don’t worry about ultra-processed anything
WASHINGTON — The food industry is anxious that regulators are focusing too much on the…
STAT+: White House touts efforts to stem cancer drug shortages
WASHINGTON — The White House says it’s working to end shortages of three key generic…
STAT+: Neurocrine Biosciences drug for congenital adrenal hyperplasia succeeds in late-stage trial
SAN DIEGO — Neurocrine Biosciences announced on Tuesday that an experimental drug for congenital adrenal…
Popular nasal decongestant doesn’t actually relieve congestion, FDA experts say
WASHINGTON — The leading decongestant used by millions of Americans looking for relief from a…
STAT+: Walmart may buy concierge Medicare Advantage provider ChenMed. But will it scale?
Walmart seems poised to increase its health care footprint by buying value-based senior care company…
Is there a path forward for PEPFAR?
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
STAT+: Pharmalittle: Is Pascal Soriot leaving AstraZeneca? PBMs try to counter congressional crackdown
Hello, everyone, and nice to see you again after our extended break. A little time…
STAT+: Nick Leschly departs Bluebird Bio spinout amid restructuring, layoffs
Some two years after splitting biotech company Bluebird Bio into two entities in a bid…
STAT+: New obesity drugs are in the works trying to out-blockbuster Wegovy and Mounjaro
The exploding popularity of drugs like Wegovy and Mounjaro has propelled dozens of companies to…
Opinion: Patients might finally receive practical information with prescriptions — if the FDA doesn’t blow it
Patients often ask two questions about every medical treatment: Will it help me? Will it…
The food industry has tried to stack a key nutrition policy panel with its preferred experts, documents show
WASHINGTON — There’s a panel of 20 nutrition experts that has outsized influence on the…